Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
Latest Information Update: 22 Nov 2022
At a glance
- Drugs Dexamethasone (Primary) ; Selinexor (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Adverse reactions
- Acronyms STARR
- 11 Nov 2022 Planned End Date changed from 1 Dec 2025 to 1 Jun 2024.
- 11 Nov 2022 Planned primary completion date changed from 1 Dec 2024 to 1 Jun 2023.
- 11 Nov 2022 Planned initiation date changed from 1 Sep 2022 to 1 Dec 2021.